Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Oct 9;10:44–51. doi: 10.1016/j.lrr.2018.10.001

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 The Author

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 2. — a. Kaplan Meier plot of overall survival of all treated patients, CNS3 vs. non-CNS3. CNS3 patients had shorter 5-year survival than non-CNS3 patients (non-CNS3 93.2% [2.6%] vs. CNS3 73.3% [9.1%]; log rank test P = 0.045). b. Kaplan Meier plot of disease free survival of all treated patients, CNS3 vs. non-CNS3. CNS3 patients had shorter 5-year survival than non-CNS3 patients (non-CNS3 90.9% [SE 3.1%] vs. CNS3 66.7% [SE 10.4%]); log rank test P = 0.0163). c. Kaplan Meier plot of overall survival of the 60 treated patients by gender. Females had shorter 5-year survival than males (F 64.3% [SE 17%] vs. M 91.9% [SE 3.4%]); log rank test P = 0.043). d. Kaplan Meier plot of disease free survival of the 60 treated patients by gender. Females had shorter 5-year survival than males (F 56% [SE 17%] vs. M 90% [SE 4.3%]); log rank test P = 0.0108).

Fig. 2. — a. Kaplan Meier plot of overall survival of all treated patients, CNS3 vs. non-CNS3. CNS3 patients had shorter 5-year survival than non-CNS3 patients (non-CNS3 93.2% [2.6%] vs. CNS3 73.3% [9.1%]; log rank test P = 0.045). b. Kaplan Meier plot of disease free survival of all treated patients, CNS3 vs. non-CNS3. CNS3 patients had shorter 5-year survival than non-CNS3 patients (non-CNS3 90.9% [SE 3.1%] vs. CNS3 66.7% [SE 10.4%]); log rank test P = 0.0163). c. Kaplan Meier plot of overall survival of the 60 treated patients by gender. Females had shorter 5-year survival than males (F 64.3% [SE 17%] vs. M 91.9% [SE 3.4%]); log rank test P = 0.043). d. Kaplan Meier plot of disease free survival of the 60 treated patients by gender. Females had shorter 5-year survival than males (F 56% [SE 17%] vs. M 90% [SE 4.3%]); log rank test P = 0.0108).